THAR
THAR
NASDAQ · Biotechnology

Tharimmune Inc

$4.07
-0.13 (-2.98%)
As of Mar 29, 10:37 PM ET ·
Financial Highlights (FY 2025)
Revenue
184.51M
Net Income
6.70M
Gross Margin
58.5%
Profit Margin
3.6%
Rev Growth
+0.4%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 58.5% 58.5% 58.5%
Operating Margin 4.9% 4.1% 3.9%
Profit Margin 3.6% 3.1% 3.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 184.51M 172.01M 149.83M
Gross Profit 108.01M 100.70M 87.71M
Operating Income 9.07M 7.10M 5.89M
Net Income 6.70M 5.27M 5.04M
Gross Margin 58.5% 58.5% 58.5%
Operating Margin 4.9% 4.1% 3.9%
Profit Margin 3.6% 3.1% 3.4%
Rev Growth +0.4% +18.6% +9.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.44M 14.55M 15.63M
Total Equity 90.07M 76.95M 84.70M
D/E Ratio 0.16 0.19 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 12.90M 10.88M 9.08M
Free Cash Flow 3.45M 3.47M 2.49M